| 标题 |
Cost-effectiveness analysis of tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma: perspectives from the United States and China |
| 网址 | |
| DOI | |
| 其它 |
期刊:Frontiers in Pharmacology 作者:Wenwang Lang; Qi Ai; Wenwen Zhang; Qin-Ling Jiang; Yulong He; et al 出版日期:2024-11-20 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)